Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation
Gwendolyn T. Wong(AIL Research (United States)), Eric M. Parker(University of New Hampshire), Maria Pinzon-Ortiz, Guy A. Higgins, Laura Engstrom, Hu-Jung J. Lee, Hubert Josien(Merck & Co., Inc., Rahway, NJ, USA (United States)), Denise Manfra, Qi Zhang, Lili Zhang(Army Medical University), Thomas Bara, Frederique M. Poulet, Jay S. Fine(Boehringer Ingelheim (United States))
Cited by 716
Related Papers
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
|Science Translational Medicine|2016|416
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition
|Journal of Pharmacology and Experimental Therapeutics|2015|336
Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells.
|Journal of Biological Chemistry|1991|283
Chimeric muscarinic cholinergic: beta-adrenergic receptors that activate Gs in response to muscarinic agonists.
|Journal of Biological Chemistry|1990|230